FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a new stable pharmaceutical composition for injections, containing 2-ethyl-6-methyl-3-oxypyridine succinate and sodium metabisulphite as a stabiliser.
EFFECT: pharmaceutical composition expresses high stability within the whole life and low toxicity.
2 cl, 3 ex
Authors
Dates
2010-01-27—Published
2008-04-04—Filed